TMEM106B and neurodegenerative disease: These studies showed that TMEM106B aggregation is a widespread pathology that exists in the post-mortem brain tissues of diverse neurodegenerative diseases, including FTLD, PD, AD, ALS and multiple system atrophy (MSA) [7–10].